Strategic Review
Strategic Review was open because of an unamed expression of interest.
Strategic was ongoing and an update was provided with Q1 results. You can listen to the Q1 conference call.
CEO called the review productive, told shareholders that the OFFER was SERIOUS, so it's no longer just an expression of interest and TLN gave Q2 guidance as a closing date.
This week, I contacted IR to ask if Q2 guidance was still on. Answer was that there was no closing date.
Obvious answer since ASCO 2009 is right here, right now.
I rejoiced myself when I heard that.
A quick closing of Strategic Review is indicative of lack of strategic option or no interest, you can check Ambrillia or countless other Biotech opening Strategic Review and closing them 2-3 months later.
A standard timeframe for Strategic Review is about 6 months. That's where we are right now.
I think it's taking longer because of recent events:
GlobeImmune Partnership deal with Celgene (Celgene dumped MYG crap, the stock Pepmoron is pumping).
GlobeImmune is a RAs inhibitor targetting lung cancer
Also, Exelixis Pi3k deal with Sanofi Aventis.
It is my guess, that there were two bidders AstraZeneca and Roche fighting (Buyout and Partnership)
Sanofi has now show their color, I think Sanofi is also in the picture now.
No closing date is now the last external evidence of how positive the strategic review is.
We might even get further interest after ASCO.
This is getting better.
We have new science backing 4601 and renewed interest.
My original investment thesis was to buy TLN to get a sure thing low ball offer at around 2$.
I am now dreaming of something between 4,5 to 15$. Most probably nearing 7$ per share.
Remember, look at Astra and Roche's actions to see their intention. It all points out to drug combo, Lung cancer war!
Tie breaker they need.
There is no other more convincing evidence other than ASCO 2009 itself.
People are now looking for hidden gems, like that Calisgo biotech PI3k inhibtor firm.
Like unknown Bi-Par.
Like TLN.
PS
What I love about Pepmoron is that from nothing this cretin
New argument to scare people : RAS is complicated!
We don't know what's going with Strategic Review so we are afraid
Since we don't know about Strategic Review and RAS, we are very confortable guessing what ROCHE and ASTRA will do.
Also, Roche and ASTRA should have done it before. So now, it's not impossible
It's a contracdiction in itsefl!!!
Geez what a cretin!